WHERE IT TREATS Muscles, tendons, ligaments, joints, and the gastrointestinal tract
For many, the initial shedding phase, combined with common minoxidil side effects (like contact dermatitis and chronic itching), makes it a difficult regimen to maintain
Why Oral BPC-157 Is Often Used for Digestive Support Because BPC-157 capsules pass through the digestive tract, they come into direct contact with the stomach and intestinal lining
A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
